| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0091-3057(01)00552-4 |
| P698 | PubMed publication ID | 11509227 |
| P2093 | author name string | Kennett GA | |
| Vickers SP | |||
| Allen NH | |||
| Porter RH | |||
| Bickerdike MJ | |||
| Malcolm CS | |||
| Easton N | |||
| P2860 | cites work | Do functional relationships exist between 5-HT1A and 5-HT2 receptors? | Q44964651 |
| Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers. | Q48880053 | ||
| Reduced satiating effect of d -fenfluramine in serotonin 5-HT 2C receptor mutant mice | Q60054745 | ||
| Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl aminopropane)-2 (DOI) | Q68565020 | ||
| Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors | Q69202649 | ||
| The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist | Q70994392 | ||
| Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells | Q24675490 | ||
| Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors | Q24681893 | ||
| 5-HT2C receptor activation decreases appetite and body weight in obese subjects | Q28253985 | ||
| Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists | Q28278816 | ||
| Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors | Q28284027 | ||
| Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated | Q28293653 | ||
| Receptor subtype and density determine the coupling repertoire of the 5-HT2 receptor subfamily | Q28611156 | ||
| Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice | Q30498829 | ||
| Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens | Q34167036 | ||
| BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats | Q34425588 | ||
| SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist | Q34432766 | ||
| Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex | Q34448363 | ||
| Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature | Q40645621 | ||
| Metoclopramide antagonism of 5-hydroxytryptophan-induced ?Wet-Dog? shake behaviour in the rat | Q40721835 | ||
| Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia | Q41165308 | ||
| Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats. | Q41835936 | ||
| Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT2C receptor levels in the rat | Q42043828 | ||
| Novel agonists of 5HT2C receptors. Synthesis and biological evaluation of substituted 2-(indol-1-yl)-1-methylethylamines and 2-(indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved therapeutics for obsessive compulsive disorder | Q42797658 | ||
| Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs | Q43864916 | ||
| P433 | issue | 3-4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 643-652 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Pharmacology, Biochemistry and Behavior | Q15716554 |
| P1476 | title | Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists | |
| P478 | volume | 69 |
| Q30484420 | 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice |
| Q36334398 | 5-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen |
| Q40672761 | A unique phenotype of 5-HT2C, agonist-induced GTPgamma35S binding, transferable to 5-HT2A and 5-HT2B, upon swapping intracellular regions |
| Q47317394 | Activation of 5-HT2A receptor disrupts rat maternal behavior |
| Q42712127 | Blockade of 5-HT2A receptors in the medial prefrontal cortex attenuates reinstatement of cue-elicited cocaine-seeking behavior in rats |
| Q34971199 | Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model |
| Q33764320 | Changes in intensity of serotonin syndrome caused by adverse interaction between monoamine oxidase inhibitors and serotonin reuptake blockers |
| Q34781182 | Characterization of serotonin-toxicity syndrome (toxidrome) elicited by 5-hydroxy-l-tryptophan in clorgyline-pretreated rats. |
| Q53080749 | Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats. |
| Q91790027 | Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice |
| Q58599010 | Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran ("FLY") and benzodifuran ("DragonFLY") analogs |
| Q34474361 | Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors. |
| Q24594834 | Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice |
| Q36316458 | Directly Observable Behavioral Effects of Lorcaserin in Rats |
| Q39768889 | Discovery and development of 5-HT(₂C) receptor agonists for obesity: is there light at the end of the tunnel? |
| Q37192714 | Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys: antagonism and apparent pA2 analyses |
| Q36915393 | Dissociating the therapeutic effects of environmental enrichment and exercise in a mouse model of anxiety with cognitive impairment. |
| Q45279141 | Effect of Hallucinogens on Unconditioned Behavior |
| Q33667703 | Effects of 5-hydroxytryptamine 2C receptor agonist MK212 and 2A receptor antagonist MDL100907 on maternal behavior in postpartum female rats |
| Q46927168 | Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: relationship with glutamate release in the medial prefrontal cortex |
| Q44574538 | Effects of serotonin 5-HT(1/2) receptor agonists in a limited-access operant food intake paradigm in the rat. |
| Q34369264 | Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response |
| Q48165414 | Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia |
| Q46240693 | Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles |
| Q90468232 | Fully automated head-twitch detection system for the study of 5-HT2A receptor pharmacology in vivo |
| Q37481197 | Further pharmacological characterization of 5-HT(2C) receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo |
| Q93118570 | Hallucinogen-Like Action of the Novel Designer Drug 25I-NBOMe and Its Effect on Cortical Neurotransmitters in Rats |
| Q24595389 | Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model |
| Q51990165 | In vivo Schild regression analyses using nonselective 5-HT2C receptor antagonists in a rat operant behavioral assay. |
| Q34359895 | Interaction of 5-HT2A and 5-HT2C Receptors in R(−)-2,5-Dimethoxy-4-iodoamphetamine-Elicited Head Twitch Behavior in Mice |
| Q30484494 | LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor |
| Q44158814 | Long-lasting change in 5-HT2A receptor-mediated behavior in rats after a single footshock |
| Q42592784 | Molecular mechanisms of serotonergic action of the HIV-1 antiretroviral efavirenz |
| Q24620764 | Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens |
| Q37306537 | Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats |
| Q44400212 | Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia. |
| Q24306644 | Pharmacological evidence for a functional serotonin-2B receptor in a human uterine smooth muscle cell line |
| Q63433406 | Preclinical characterization of toluene as a non-classical hallucinogen drug in rats: participation of 5-HT, dopamine and glutamate systems |
| Q30359998 | Psychedelics |
| Q27027381 | Recent advances in the neuropsychopharmacology of serotonergic hallucinogens |
| Q44892908 | Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice |
| Q36755908 | Regulation of rat cortical 5-hydroxytryptamine2A receptor-mediated electrophysiological responses by repeated daily treatment with electroconvulsive shock or imipramine |
| Q50038117 | Repeated administration of 5-hydroxytryptamine 2C agonist MK212 produces a sensitization effect of antipsychotic activity |
| Q37619179 | Restricted access to standard or high fat chow alters sensitivity of rats to the 5-HT(2A/2C) receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane. |
| Q28276150 | Return of the lysergamides. Part II: Analytical and behavioural characterization of N(6) -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ) |
| Q46573497 | Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775). |
| Q48579016 | Rewarding properties of 1-benzylpiperazine, a new drug of abuse, in rats |
| Q48370760 | Role of atypical opiates in OCD. Experimental approach through the study of 5-HT(2A/C) receptor-mediated behavior. |
| Q27308143 | Seizure-dependent mTOR activation in 5-HT neurons promotes autism-like behaviors in mice |
| Q36427038 | Selective 5HT2A and 5HT6 receptor antagonists promote sleep in rats |
| Q35072812 | Serotonin (5-hydroxytryptamine) 5-HT(2A) receptor: association with inherent and cocaine-evoked behavioral disinhibition in rats |
| Q46937759 | Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse. |
| Q30855118 | Sertraline Induces Toxicity and Behavioral Alterations in Planarians |
| Q46979184 | Stimulation of serotonin2C receptors influences cocaine-seeking behavior in response to drug-associated stimuli in rats |
| Q44403871 | Swim stress inhibits 5-HT2A receptor-mediated head twitch behaviour in mice |
| Q34177643 | Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders |
| Q37122707 | The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents |
| Q47677518 | The behavioral pharmacology and therapeutic potential of lorcaserin for substance use disorders |
| Q24620468 | The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen |
Search more.